Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
CRLX101 Plus Bevacizumab in Advanced RCC
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Ranibizumab and Bevacizumab for Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics and Safety Study of BI 695502 in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Translational Study of Bevacizumab in Participants With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE4
An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study
- Status
- COMPLETED
- Phase
- PHASE4
Phase I/II Bevacizumab Versus Bevacizumab Plus TPI 287 for Recurrent Glioblastoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Triamcinolone Acetonide Combined With Laser, Bevacizumab Combined With Laser Versus Laser Alone for the Treatment of Diffuse Non-tractional Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- PHASE3
A Phase 2 Evaluation of TRC105 In Combination With Bevacizumab in Patients With Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
BELIEF (Bevacizumab and ErLotinib In EGFR Mut+ NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2